Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;73(7):911-916.
doi: 10.1007/s00228-017-2247-x. Epub 2017 Apr 6.

Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine

Affiliations

Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine

Kai-Ming Jhang et al. Eur J Clin Pharmacol. 2017 Jul.

Erratum in

Abstract

Purpose: Flunarizine (fz) and cinnarizine (cz) have well-known extrapyramidal side effects (EPSEs). The aim of this study was to evaluate the incidence and occurrence time of cz- and fz-related EPSEs.

Method: Patients who took fz or cz for more than 1 month were identified from the longitudinal health insurance database 2005 and 2010. Excluded were patients with any of the underlying diseases that may cause parkinsonism. Drug-induced EPSEs were defined as the new diagnosis of parkinsonism, dyskinesia, or secondary dystonia during drug use or within 3 months after discontinuing the medication. Age- and sex-matched controls were included in this study.

Results: Recruited for analysis were individuals who took fz (n = 26,133) and cz (n = 7186). The incidence rates of fz- and cz-induced EPSEs were 21.03 and 10.3 per 10,000 person-months, respectively. The hazard ratios (HRs) of EPSEs among fz and cz subjects were 8.03 (95% CI 6.55-9.84) and 3.41 (95% CI 2.50-4.63) when compared with the control individuals. Both fz and cz patients had a higher cumulative incidence of EPSEs than their control individuals (p < 0.001). Among subjects who took fz, the incidence of EPSEs was higher in the second than first year of drug exposure (45.59 vs 21.03 per 10,000 person-months).

Conclusions: Fz and cz significantly increased the risk of parkinsonism, dyskinesia, and dystonia. Potential benefits and risks should be weighed when considering long-term use of these drugs especially fz.

Keywords: Calcium channel blocker; Cinnarizine; Extrapyramidal symptom; Flunarizine; Movement disorder; National Health Insurance Research Database; Taiwan.

PubMed Disclaimer

Conflict of interest statement

Source of funding

None.

Conflict of interest

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Kaplan-Meier plot of cumulative incidence proportion of parkinsonism or dyskinesia/dystonia by groups

References

    1. Susatia F, Fernandez HH. Drug-induced parkinsonism. Curr Treat Options Neurol. 2009;11(3):162–169. doi: 10.1007/s11940-009-0019-3. - DOI - PubMed
    1. M-S SE (1984) Flunarizina, parkinsonismo e depressão. XI Congresso Brasileiro de Neurologia, Goiânia, Goiás, Brasil. Abstracts
    1. Chouza C, et al. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine. Lancet. 1986;1(8493):1303–1304. doi: 10.1016/S0140-6736(86)91223-7. - DOI - PubMed
    1. Gimenez-Roldan S, Mateo D. Cinnarizine-induced parkinsonism. Susceptibility related to aging and essential tremor. Clin Neuropharmacol. 1991;14(2):156–164. doi: 10.1097/00002826-199104000-00005. - DOI - PubMed
    1. Marti-Masso JF, Poza JJ. Cinnarizine-induced parkinsonism: ten years later. Mov Disord. 1998;13(3):453–456. doi: 10.1002/mds.870130313. - DOI - PubMed

LinkOut - more resources